Biomaterials Market

Biomaterials Market by Type (Metallic (Gold, Magnesium), Ceramic (Aluminum Oxide, Carbon), Polymer (Polyethylene, Polyester), Natural (Hyaluronic acid, Collagen, Gelatin)), Application (Orthopedic, Dental, CVD, Ophthalmology) & Region - Global Forecast to 2029

Report Code: BT 1556 Mar, 2024, by marketsandmarkets.com

The global biomaterials market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. This is mainly due to various factors such as growing funding and investments in regenerative and personalized medicine, increase in the use of biomaterials in various therapeutic areas, rising demand for biomaterials in wound healing and plastic surgery and growing demand for implantable devices. However, the bioincompatibility issues are predicted to cause market growth barriers.

Biomaterials Market Market Size, Dynamics & Ecosystem

Biomaterials Market Size, Dynamics & Ecosystem

To know about the assumptions considered for the study, Request for Free Sample Report

Global Biomaterials Market Dynamics

Driver: Growing demand for biomaterials in wound healing and plastic surgery

Plastic surgery and wound healing are prominent application areas for biomaterial-based products. In plastic surgery, biomaterials are widely used to implant, rebuild, repair, and cover soft tissue wounds, burns, or gaping holes in the human body naturally and safely. The surge in demand for biomaterials in wound healing and plastic surgery is a significant driver within the medical industry. There has been a notable increase in the adoption of biomaterials, driven by their proven efficacy in promoting enhanced healing processes and reducing infection rates in medical procedures..

Restraint: Biocompatibility issues

Orthopedic injuries and associated pathologies represent a significant global public health concern and a substantial burden of disability and suffering. In the global context, there was a notable surge in musculoskeletal disorders, with a recorded total of 494 million individuals affected in 2020. This signifies a substantial rise of 123.4% compared to the 1990 statistics, which reported 221 million cases. These orthopedic conditions often necessitate surgical interventions, involving the utilization of permanent, temporary, or biodegradable medical devices. These devices incorporate various natural or synthetic biomaterials designed to substitute or repair different tissues, such as ligaments, tendons, cartilage, and bone. The success of orthopedic interventions relies significantly on the careful consideration of factors like the design of the medical device, the functional properties of biomaterials, and the biological response.

Opportunity: Growing interest in bio-absorbable biomaterials

Bioresorbable refers to a substance that when introduced into the human body, initiates a process of dissolution (resorption) and gradual replacement by advancing tissue, such as bone. Examples of bioresorbable materials include tricalcium phosphate [Ca3(PO4)2] and copolymers of polylactic acid and polyglycolic acid. In the past three decades, commonly utilized materials with bioresorbable properties also encompass calcium oxide, calcium carbonate, and gypsum. The biomaterials industry is witnessing a surge in interest in bioabsorbable biomaterials, indicating a paradigm shift in the field. According to data from reputable industry reports between 2021–2024, this growing interest is substantiated by a notable increase in investments, with major companies focusing on research, development, and commercialization of bioabsorbable materials. Examples include the Absorv range of bioabsorbable products by Zeus Company Inc. (EQT AB) and the RESOMER range of bioresorbable materials by Evonik Industries AG.

Challenge: Durability and long-term performance issues

The biomaterials market is expanding at a fast pace; however, long-term durability and performance pose a challenge to the market growth. Maintaining functionality and efficacy over time poses a major challenge, impacting patient outcomes and market potential. Furthermore, biomaterials find widespread applications in various medical devices, encompassing implants, scaffolds, dental products, prostheses, stents, catheters, and artificial organs. Following the fulfillment of their intended purposes, these biomaterials undergo replacement or removal. With the escalating significance of biomaterials in the realm of medicine, their accumulation and disposal in medical waste pose a growing challenge. Commonly, waste biomaterials are either deposited in landfills or subjected to incineration. However, given their potential infectious nature, biomaterials discarded in landfills may pose environmental risks, contributing to soil and water pollution during degradation. Conversely, insufficient incineration of biomaterials may result in the emission of harmful chemical compounds into the atmosphere. Hence, the imperative to address biomaterial recycling is of immediate concern. These are the major reasons why maintenance of durability and performance in the long run and waste management of biomaterials can limit their use.

Biomaterials Market Segmentation & Geographical Spread

Biomaterials Market Segmentation & Geographical Spread

To know about the assumptions considered for the study, download the pdf brochure

The metallic biomaterials segment commanded market share of biomaterials industry in 2023.

On the basis of type, the biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver,  magnesium, and other metallic biomaterials), polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, polyetheretherketone, other polymeric biomaterials), ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon and glass) and natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, other natural biomaterials). The metallic biomaterials segment dominated the market in 2023. The advancements in material science and manufacturing technologies and increasing demand for orthopedic implants are a few of the many factors driving the growth of this segment.

The orthopedic application is poised to exhibit substantial growth at a notable CAGR throughout the biomaterials industry forecast period.

Based on application, the biomaterials market is classified into Cardiovascular (Heart Valves, Stents, Cardiac Defibrillators, Guidewires, Sensors, Catheters, Vascular Grafts, Other Cardiovascular Products), Implantable Wound Healing (Skin Substitutes, Wound Closure Devices, [Sutures, Staples], Surgical Hemostats, Adhesion Barriers, Hernia Meshes, Internal Tissue Sealants), Orthopedic (Joint Replacement [Knee Replacement, Shoulder Replacement, Hip Replacement, Other Joint Replacement Procedures], Spine Surgery, [Minimally Invasive Fusion, Motion Preservation & Dynamic Stabilization {Pedicle-based Rod Systems, Interspinous Spacers, Artificial Discs}, Spinal Fusion], Bioresorbable Tissue Fixation [Meniscal Repair Tacks, Suture Anchors, Interference Screws, Meshes], Orthobiologics, Fracture Fixation [Wires, Screws, Bone Plates, Pins, Rods]), Urinary (Urinary Catheters, Urethral Stents, Other Urinary Products), Dental (Dental Implants, Tissue Regeneration Materials, Dental Bone Grafts & Substitutes, Dental Membranes), Plastic Surgery (Facial Wrinkle Treatment Devices, Acellular Dermal Matrices, Bioengineered Skins, Craniofacial Surgery Products, Peripheral Nerve Repair Devices, Soft Tissue Fillers), Tissue Engineering (Scaffolds, Inorganic Nanoparticles, Nanomaterials), Neurological/Central Nervous System (Cortical Neural Prosthetics, Shunting Systems, Neural Stem Cell Encapsulation Products, Hydrogel Scaffolds), Ophthalmology (Contact Lenses, Functional Replacement of Ocular Tissues, Intraocular Lenses, Synthetic Corneas, Other Ophthalmology Products), and Other Applications (Drug Delivery Systems, Bariatric Surgery, Gastrointestinal). In 2023, the orthopedic sector dominated the global market, primarily driven by heightened research into musculoskeletal regeneration and the growing incidence of orthopedic conditions.

Biomaterials Industry, Asia Pacific predicted to exhibit highest CAGR during the forecast period of 2024-2029.

There are six main regional segmentations for the biomaterials market—North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2023, North America was estimated to account for the highest market share. Advanced healthcare infrastructure, favorable regulatory environment and increasing incidence of chronic diseases are driving the North American market's robust growth. Additionally, Asia Pacific was estimated to exhibit the highest CAGR which can be attributed to the increase in the aging population, rising new technologies demand and increasing burden of chronic diseases.

Key players in the Market include BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).

Scope of the Biomaterials Industry

Report Metric

Details

Market Revenue in 2024

$45.2 billion

Projected Revenue by 2029

$64.2 billion

Revenue Rate

Poised to Grow at a CAGR of 7.3%

Market Driver

Growing demand for biomaterials in wound healing and plastic surgery

Market Opportunity

Growing interest in bio-absorbable biomaterials

This report categorizes the biomaterials market to forecast revenue and analyze trends in each of the following submarkets:

By Type

  • Metallic Biomaterials
    • Stainless Steel
    • Titanium & Titanium Alloys
    • Cobalt-chrome Alloys
    • Silver
    • Gold
    • Magnesium
    • Other Metallic Biomaterials
  • Ceramic Biomaterials
    • Aluminum Oxide
    • Zirconia
    • Calcium Phosphate
    • Calcium Sulfate
    • Carbon
    • Glass
  • Polymeric Biomaterials
    • Polymethylmethacrylate
    • Polyethylene
    • Polyester
    • Polyvinylchloride
    • Silicone Rubber
    • Nylon
    • Polyetheretherketone
    • Other Polymeric Biomaterials
  • Natural Biomaterials
    • Hyaluronic Acid
    • Collagen
    • Fibrin
    • Cellulose
    • Chitin
    • Alginate
    • Gelatin
    • Silk
    • Chitosan
    • Other Natural Biomaterials
  • Cell therapy
    • Stem cell therapy
      • Cell transplantations
      • Stem cell therapy products
        • Autologous therapy
        • Allogenic therapy
    • Cell-based immunotherapy products
  • Gene therapy
  • Tissue engineering

By Application

  • Cardiovascular
    • Catheters
    • Stents
    • Implantable Cardiac Defibrillators
    • Sensors
    • Heart Valves
    • Vascular Grafts
    • Guidewires
    • Other Cardiovascular Products
  • Orthopedic
    • Joint Replacement
      • Knee Replacement
      • Hip Replacement
      • Shoulder Replacement
      • Other Joint Replacement Procedures
    • Spine Surgery
      • Spinal Fusion
      • Minimally Invasive Fusion
      • Motion Preservation & Dynamic Stabilization
        • Pedicle-based Rod Systems
        • Interspinous Spacers
        • Artificial Discs
    • Bioresorbable Tissue Fixation
      • Suture Anchors
      • Interference Screws
      • Meniscal Repair Tacks
      • Meshes
    • Orthobiologics
    • Fracture Fixation
      • Bone Plates
      • Screws
      • Pins
      • Rods
      • Wires
  • Ophthalmology
    • Contact Lenses
    • Intraocular Lenses
    • Functional Replacement of Ocular Tissues
    • Synthetic Corneas
    • Other Ophthalmology Products
  • Dental
    • Dental Implants
    • Dental Bone Grafts & Substitutes
    • Dental Membranes
    • Tissue Regeneration Materials
  • Plastic Surgery
    • Soft Tissue Fillers
    • Craniofacial Surgery Products
    • Facial Wrinkle Treatment Devices
    • Bioengineered Skins
    • Peripheral Nerve Repair Devices
    • Acellular Dermal Matrices
  • Wound Healing
    • Wound Closure Devices
      • Sutures
      • Staples
    • Internal Tissue Sealants
    • Surgical Hemostats
    • Adhesion Barriers
    • Hernia Meshes
    • Skin Substitutes
  • Tissue Engineering
    • Scaffolds
    • Nanomaterials
    • Inorganic Nanoparticles
  • Neurological/Central Nervous System
    • Shunting Systems
    • Cortical Neural Prosthetics
    • Hydrogel Scaffolds
    • Neural Stem Cell Encapsulation Products
  • Urinary
    • Urinary Catheters
    • Urethral Stents
    • Other Urinary Products
  • Other Applications
    • Drug Delivery Systems
    • Gastrointestinal
    • Bariatric Surgery

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • GCC
      • Saudi Arabia (KSA)
      • United Arab Emirates (UAE)
      • Rest of GCC
    • Rest of Middle East
  • Africa

Recent Developments of Biomaterials Industry:

  • In October 2022, BASF launched two new sustainable product families: Ultraform LowPCF (Low Product Carbon Footprint) and Ultraform BMB (Biomass Balance) to support the sustainability goals of the customer. BASF has designated Ultraform as its trademark for the polyoxymethylene (POM) portfolio. Ultraform LowPCF presents a Product Carbon Footprint that surpasses conventional Ultraform grades by a minimum of 30% through the utilization of green electricity and the implementation of energy-efficient technology.
  • In February 2023, Covestro launched Makrolon 3638 polycarbonate for use in both healthcare and life science applications. This polycarbonate grade is durable, with the ability to withstand everyday use while maintaining structural integrity.
  • In September 2022, Celanese Corporation entered into a strategic agreement with polymer distributor Ravago for Celanese's Santoprene and Geolast TPV portfolio in North American countries, such as the US, Canada, and Mexico.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 89)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 RESEARCH LIMITATIONS 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 94)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
          FIGURE 2 BIOMATERIALS MARKET: BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 BIOMATERIALS INDUSTRY SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
          FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023
          FIGURE 5 ILLUSTRATIVE EXAMPLE OF BASF SE: REVENUE SHARE ANALYSIS, 2023
           2.2.1 INSIGHTS FROM PRIMARIES
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENT ASSESSMENT (BY TYPE AND APPLICATION)
                    FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
          FIGURE 8 BIOMATERIALS INDUSTRY: CAGR PROJECTIONS, 2024–2029
          FIGURE 9 MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RISK ANALYSIS 
    2.7 IMPACT OF ECONOMIC RECESSION ON MARKET 
          TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 106)
    FIGURE 11 BIOMATERIALS MARKET, BY TYPE, 2024 VS 2029 (USD BILLION)
    FIGURE 12 BIOMATERIALS INDUSTRY FOR METALLIC BIOMATERIALS, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 13 MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2024 VS. 2029 (USD MILLION)
    FIGURE 14 REGIONAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 110)
    4.1 BIOMATERIALS MARKET OVERVIEW 
          FIGURE 15 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE MARKET
    4.2 NORTH AMERICA: BIOMATERIALS INDUSTRY, BY TYPE AND COUNTRY (2023) 
          FIGURE 16 US AND METALLIC BIOMATERIALS COMMANDED LARGEST SHARE IN NORTH AMERICAN MARKET IN 2023
    4.3 MARKET, BY TYPE 
          FIGURE 17 METALLIC BIOMATERIALS TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET, BY APPLICATION 
          FIGURE 18 ORTHOPEDIC SEGMENT TO GROW AT HIGHEST CAGR DURING STUDY PERIOD
 
5 MARKET OVERVIEW (Page No. - 114)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Growing demand for biomaterials in wound healing and plastic surgery
                    5.2.1.2 Growing use of biomaterials in various therapeutic areas
                    5.2.1.3 Rising funding and investments in regenerative and personalized medicine
                    5.2.1.4 Growing demand for implantable devices
           5.2.2 RESTRAINTS
                    5.2.2.1 Biocompatibility issues
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing interest in bioabsorbable biomaterials
                    5.2.3.2 Expanding healthcare market in emerging economies
                    5.2.3.3 Rising opportunities in personalized, smart, nanoengineered, and sustainable biomaterials
           5.2.4 CHALLENGES
                    5.2.4.1 Durability and long-term performance issues
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 20 BIOMATERIALS INDUSTRY: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
    5.4 PRICING ANALYSIS 
           5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
                    TABLE 4 AVERAGE SELLING PRICE OF BIOMATERIAL PRODUCTS
                    TABLE 5 AVERAGE SELLING TREND OF BIOMATERIAL PRODUCTS, BY REGION
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 21 MARKET: VALUE CHAIN ANALYSIS
    5.6 SUPPLY CHAIN ANALYSIS 
          FIGURE 22 MARKET: SUPPLY CHAIN ANALYSIS
          TABLE 6 MARKET: SUPPLY CHAIN ANALYSIS
    5.7 ECOSYSTEM ANALYSIS 
          FIGURE 23 MARKET: ECOSYSTEM/MARKET MAP
           5.7.1 METALLIC BIOMATERIALS VENDORS
                    TABLE 7 METALLIC BIOMATERIALS VENDORS
           5.7.2 CERAMIC BIOMATERIALS VENDORS
                    TABLE 8 CERAMIC BIOMATERIALS VENDORS
           5.7.3 POLYMERIC BIOMATERIALS VENDORS
                    TABLE 9 POLYMERIC BIOMATERIALS VENDORS
           5.7.4 NATURAL BIOMATERIALS VENDORS
                    TABLE 10 NATURAL BIOMATERIALS VENDORS
           5.7.5 BIOMATERIALS END USERS
                    TABLE 11 BIOMATERIALS END USERS
           5.7.6 BIOMATERIALS REGULATORY BODIES
                    TABLE 12 BIOMATERIALS REGULATORY BODIES
    5.8 TECHNOLOGY ANALYSIS 
    5.9 PATENT ANALYSIS 
           5.9.1 METHODOLOGY
           5.9.2 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
                    TABLE 13 PATENTS FILED, 2014–2024
           5.9.3 INNOVATION AND PATENT APPLICATIONS
                    FIGURE 24 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023
           5.9.4 TOP APPLICANTS
                    FIGURE 25 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
                    FIGURE 26 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024
                    TABLE 14 TOP 12 PATENT OWNERS IN BIOMATERIALS INDUSTRY, 2014–2024
                    TABLE 15 PATENTS IN MARKET, 2023
    5.10 TRADE DATA 
           5.10.1 STAINLESS STEEL
                     TABLE 16 IMPORT VALUE FOR STAINLESS STEEL, 2018–2022 (USD)
                     TABLE 17 EXPORT VALUE FOR STAINLESS STEEL, 2018–2022 (USD)
                     TABLE 18 IMPORT VOLUME FOR STAINLESS STEEL, 2018–2022 (TONS)
                     TABLE 19 EXPORT VOLUME FOR STAINLESS STEEL, 2018–2022 (TONS)
           5.10.2 SILVER
                     TABLE 20 IMPORT VALUE FOR SILVER, 2018–2022 (USD)
                     TABLE 21 EXPORT VALUE FOR SILVER, 2018–2022 (USD)
                     TABLE 22 IMPORT VOLUME FOR SILVER, 2018–2022 (TONS)
                     TABLE 23 EXPORT VOLUME FOR SILVER, 2018–2022 (TONS)
           5.10.3 ALUMINUM OXIDE
                     TABLE 24 IMPORT VALUE FOR ALUMINUM OXIDE, 2018–2022 (USD)
                     TABLE 25 EXPORT VALUE FOR ALUMINUM OXIDE, 2018–2022 (USD)
                     TABLE 26 IMPORT VOLUME FOR ALUMINUM OXIDE, 2018–2022 (TONS)
                     TABLE 27 EXPORT VOLUME FOR ALUMINUM OXIDE, 2018–2022 (TONS)
           5.10.4 SILICONE
                     TABLE 28 IMPORT VALUE FOR SILICONE, 2018–2022 (USD)
                     TABLE 29 EXPORT VALUE FOR SILICONE, 2018–2022 (USD)
                     TABLE 30 IMPORT VOLUME FOR SILICONE, 2018–2022 (TONS)
                     TABLE 31 EXPORT VOLUME FOR SILICONE, 2018–2022 (TONS)
           5.10.5 CELLULOSE
                     TABLE 32 IMPORT VALUE FOR CELLULOSE, 2018–2022 (USD)
                     TABLE 33 EXPORT VALUE FOR CELLULOSE, 2018–2022 (USD)
                     TABLE 34 IMPORT VOLUME FOR CELLULOSE, 2018–2022 (TONS)
                     TABLE 35 EXPORT VOLUME FOR CELLULOSE, 2018–2022 (TONS)
           5.10.6 GELATIN
                     TABLE 36 IMPORT VALUE FOR GELATIN, 2018–2022 (USD)
                     TABLE 37 EXPORT VALUE FOR GELATIN, 2018–2022 (USD)
                     TABLE 38 IMPORT VOLUME FOR GELATIN, 2018–2022 (TONS)
                     TABLE 39 EXPORT VOLUME FOR GELATIN, 2018–2022 (TONS)
    5.11 KEY CONFERENCES & EVENTS IN 2024–2025 
           TABLE 40 BIOMATERIALS CONFERENCES IN 2024–2025
    5.12 REGULATORY LANDSCAPE 
           5.12.1 FDA REGULATIONS ON BIOMATERIALS
           5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 41 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 42 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 43 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                     TABLE 44 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.13 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 45 MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.13.1 THREAT OF NEW ENTRANTS
           5.13.2 THREAT OF SUBSTITUTES
           5.13.3 BARGAINING POWER OF BUYERS
           5.13.4 BARGAINING POWER OF SUPPLIERS
           5.13.5 DEGREE OF COMPETITION
    5.14 KEY STAKEHOLDERS & BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 46 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
           5.14.2 BUYING CRITERIA FOR BIOMATERIAL PRODUCTS
                     FIGURE 27 KEY BUYING CRITERIA FOR END USERS
                     TABLE 47 KEY BUYING CRITERIA FOR TOP THREE END USERS
 
6 BIOMATERIALS MARKET, BY TYPE (Page No. - 161)
    6.1 INTRODUCTION 
          TABLE 48 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
          TABLE 49 BIOMATERIALS INDUSTRY, BY TYPE, 2022–2029 (USD MILLION)
    6.2 METALLIC BIOMATERIALS 
          TABLE 50 MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 51 MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)
           6.2.1 STAINLESS STEEL
                    6.2.1.1 Stainless steel to command largest share in metallic biomaterials segment during forecast period
                                TABLE 52 STAINLESS STEEL MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.2 TITANIUM & TITANIUM ALLOYS
                    6.2.2.1 Growing number of joint replacement procedures to aid segment growth
                                TABLE 53 TITANIUM & TITANIUM ALLOYS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.3 COBALT-CHROME ALLOYS
                    6.2.3.1 Low cost and high corrosion resistance to propel segment growth
                                TABLE 54 COBALT-CHROME ALLOYS MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.4 SILVER
                    6.2.4.1 Toxic properties and low aesthetic appeal to limit segment growth
                                TABLE 55 SILVER MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.5 GOLD
                    6.2.5.1 Increasing use in drug delivery, gene therapy, diagnosis, and tissue regeneration to drive segment
                                TABLE 56 GOLD MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.6 MAGNESIUM
                    6.2.6.1 High biocompatibility and low weight to support market growth
                                TABLE 57 MAGNESIUM MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.2.7 OTHER METALLIC BIOMATERIALS
                    TABLE 58 OTHER METALLIC BIOMATERIALS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.3 POLYMERIC BIOMATERIALS 
          TABLE 59 APPLICATIONS OF SYNTHETIC POLYMERS
          TABLE 60 MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 61 MARKET FOR POLYMERIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)
           6.3.1 POLYMETHYLMETHACRYLATE
                    6.3.1.1 Better biocompatibility and improved safety to drive segment
                                TABLE 62 POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.2 POLYETHYLENE
                    6.3.2.1 Better wear and tear resistance to boost segment growth
                                TABLE 63 POLYETHYLENE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.3 POLYESTER
                    6.3.3.1 Better biodegradability and biocompatibility to propel segment growth
                                TABLE 64 POLYESTER MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.4 POLYVINYLCHLORIDE
                    6.3.4.1 Affordability, high tensile strength, and ease of processing to drive segment growth
                                TABLE 65 POLYVINYLCHLORIDE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.5 SILICONE RUBBER
                    6.3.5.1 Non-reactivity, stability, and better resistance to extreme environments and temperatures to aid segment growth
                                TABLE 66 SILICONE RUBBER MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.6 NYLON
                    6.3.6.1 Increased use in biological applications and gastrointestinal surgeries to aid segment growth
                                TABLE 67 NYLON MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.7 POLYETHERETHERKETONE
                    6.3.7.1 High resistanace to thermal degradation and aqueous environments to support segment growth
                                TABLE 68 POLYETHERETHERKETONE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.3.8 OTHER POLYMERIC BIOMATERIALS
                    TABLE 69 OTHER POLYMERIC MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.4 CERAMIC BIOMATERIALS 
          TABLE 70 MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 71 MARKET FOR CERAMIC BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)
           6.4.1 CALCIUM PHOSPHATE
                    6.4.1.1 Better affinity to human body and higher bioresorbability to drive segment
                                TABLE 72 CALCIUM PHOSPHATE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.2 ZIRCONIA
                    6.4.2.1 Bio-inertness and low wear rate to aid market growth
                                TABLE 73 ZIRCONIA MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.3 ALUMINUM OXIDE
                    6.4.3.1 Increasing use in hip replacements and dental implants to drive segment
                                TABLE 74 ALUMINUM OXIDE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.4 CALCIUM SULFATE
                    6.4.4.1 Increased popularity and adoption of tissue regeneration products to limit segment growth
                                TABLE 75 CALCIUM SULFATE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.5 CARBON
                    6.4.5.1 Increasing use in regenerative medicine and cancer treatment to drive segment
                                TABLE 76 CARBON MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.4.6 GLASS
                    6.4.6.1 Rising number of orthopedic and dental procedures to boost segment growth
                                TABLE 77 GLASS MARKET, BY REGION, 2022–2029 (USD MILLION)
    6.5 NATURAL BIOMATERIALS 
          TABLE 78 APPLICATIONS OF NATURAL BIOMATERIALS
          TABLE 79 MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 80 MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2022–2029 (USD MILLION)
           6.5.1 HYALURONIC ACID
                    6.5.1.1 Rising prevalence of osteoarthritis among geriatric population to drive segment
                                TABLE 81 HYALURONIC ACID MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.2 COLLAGEN
                    6.5.2.1 Biocompatibility, biodegradability, accessibility, and efficient production processes to drive market
                                TABLE 82 COLLAGEN MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.3 FIBRIN
                    6.5.3.1 High utilization in wound healing and blood clotting to aid market growth
                                TABLE 83 FIBRIN MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.4 CELLULOSE
                    6.5.4.1 Better biodegradability, water-retention capability, and renewability to propel market growth
                                TABLE 84 CELLULOSE MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.5 CHITIN
                    6.5.5.1 Increased use in biomedical sector for wound dressings, drug delivery, and bone repair to drive market
                                TABLE 85 CHITIN MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.6 ALGINATES
                    6.5.6.1 Increased use in gastric reflux treatment to propel market growth
                                TABLE 86 ALGINATES MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.7 GELATIN
                    6.5.7.1 Cost-effectiveness and easy manufacturing process to drive segment growth
                                TABLE 87 GELATIN MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.8 CHITOSAN
                    6.5.8.1 Non-toxicity, antimicrobial attributes, and functional versatility to aid market growth
                                TABLE 88 CHITOSAN MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.9 SILK
                    6.5.9.1 Flexibility, glossiness, and adhesive abilities to boost market growth
                                TABLE 89 SILK MARKET, BY REGION, 2022–2029 (USD MILLION)
           6.5.10 OTHER NATURAL BIOMATERIALS
                     TABLE 90 OTHER NATURAL MARKET, BY REGION, 2022–2029 (USD MILLION)
 
7 BIOMATERIALS MARKET, BY APPLICATION (Page No. - 199)
    7.1 INTRODUCTION 
          TABLE 91 BIOMATERIALS INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
    7.2 ORTHOPEDIC 
          TABLE 92 MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 93 MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.2.1 JOINT REPLACEMENT
                    TABLE 94 MARKET FOR JOINT REPLACEMENT APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 95 MARKET FOR JOINT REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.1.1 Knee replacement
                               7.2.1.1.1 Growing number of knee replacement procedures to drive market growth
                                              TABLE 96 MARKET FOR KNEE REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.1.2 Hip replacement
                               7.2.1.2.1 Large number of procedures performed to support market growth
                                              TABLE 97 MARKET FOR HIP REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.1.3 Shoulder replacement
                               7.2.1.3.1 Extensive use of biomaterials in shoulder replacement procedures to boost market
                                              TABLE 98 BIOMATERIALS INDUSTRY FOR SHOULDER REPLACEMENT APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.1.4 Other joint replacement procedures
                                TABLE 99 MARKET FOR OTHER JOINT REPLACEMENT PROCEDURES, BY REGION, 2022–2029 (USD MILLION)
           7.2.2 BIORESORBABLE TISSUE FIXATION
                    TABLE 100 MARKET FOR BIORESORBABLE TISSUE FIXATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 101 MARKET FOR BIORESORBABLE TISSUE FIXATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.1 Suture anchors
                               7.2.2.1.1 Growing awareness about suture anchor devices to drive market growth
                                              TABLE 102 MARKET FOR SUTURE ANCHORS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.2 Interference screws
                               7.2.2.2.1 Increasing awareness about ACL to contribute to market growth
                                              TABLE 103 MARKET FOR INTERFERENCE SCREWS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.3 Meniscal repair tacks
                               7.2.2.3.1 Rising sports injuries to drive growth
                                              TABLE 104 BIOMATERIALS MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.2.4 Meshes
                               7.2.2.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants to increase demand for meshes
                                              TABLE 105 MARKET FOR MESHES, BY REGION, 2022–2029 (USD MILLION)
           7.2.3 SPINE SURGERY
                    TABLE 106 MARKET FOR SPINE SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 107 MARKET FOR SPINE SURGERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.3.1 Spinal fusion
                               7.2.3.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
                                              TABLE 108 MARKET FOR SPINAL FUSION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.3.2 Minimally invasive fusion
                               7.2.3.2.1 Faster recovery associated with minimally invasive fusion procedures to drive demand
                                              TABLE 109 MARKET FOR MINIMALLY INVASIVE FUSION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.3.3 Motion preservation & dynamic stabilization
                                TABLE 110 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
                                TABLE 111 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                               7.2.3.3.1 Pedicle-based rod systems
                                             7.2.3.3.1.1 Rising geriatric population to favor market growth
                                                              TABLE 112 BIOMATERIALS INDUSTRY FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
                               7.2.3.3.2 Interspinous spacers
                                             7.2.3.3.2.1 High prevalence of degenerative spinal conditions to contribute to growth
                                                              TABLE 113 MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2022–2029 (USD MILLION)
                               7.2.3.3.3 Artificial discs
                                             7.2.3.3.3.1 High biocompatibility to increase use of artificial discs
                                                              TABLE 114 MARKET FOR ARTIFICIAL DISCS, BY REGION, 2022–2029 (USD MILLION)
           7.2.4 FRACTURE FIXATION
                    TABLE 115 MARKET FOR FRACTURE FIXATION APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
                    TABLE 116 MARKET FOR FRACTURE FIXATION APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.4.1 Bone plates
                               7.2.4.1.1 Growing use of biomaterials in bone plates to aid growth
                                              TABLE 117 MARKET FOR BONE PLATES, BY REGION, 2022–2029 (USD MILLION)
                    7.2.4.2 Screws
                               7.2.4.2.1 Extensive use of screws in orthopedic procedures to boost market
                                              TABLE 118 MARKET FOR SCREWS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.4.3 Pins
                               7.2.4.3.1 Growing use of metallic biomaterials in pins to propel growth
                                              TABLE 119 BIOMATERIALS MARKET FOR PINS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.4.4 Rods
                               7.2.4.4.1 Growing preference for rods for fracture treatment to fuel growth
                                              TABLE 120 MARKET FOR RODS, BY REGION, 2022–2029 (USD MILLION)
                    7.2.4.5 Wires
                               7.2.4.5.1 Extensive use of wires to treat fractures of small bones to aid growth
                                              TABLE 121 MARKET FOR WIRES, BY REGION, 2022–2029 (USD MILLION)
           7.2.5 ORTHOBIOLOGICS
                    7.2.5.1 Rising cases of osteoarthritis to drive growth
                                              TABLE 122 MARKET FOR ORTHOBIOLOGICS APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
    7.3 CARDIOVASCULAR 
          TABLE 123 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 124 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.3.1 CATHETERS
                    7.3.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive market
                                TABLE 125 MARKET FOR CATHETERS, BY REGION, 2022–2029 (USD MILLION)
           7.3.2 STENTS
                    7.3.2.1 Increasing number of coronary intervention procedures to boost demand for implantable stents
                                TABLE 126 BIOMATERIALS INDUSTRY FOR STENTS, BY REGION, 2022–2029 (USD MILLION)
           7.3.3 IMPLAN                                TABLE CARDIAC DEFIBRILLATORS
                    7.3.3.1 Growing geriatric population to increase demand for implantable cardiac defibrillators
                                TABLE 127 MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2022–2029 (USD MILLION)
           7.3.4 PACEMAKERS
                    7.3.4.1 High prevalence of bradycardia to drive demand for pacemakers
                                TABLE 128 MARKET FOR PACEMAKERS, BY REGION, 2022–2029 (USD MILLION)
           7.3.5 SENSORS
                    7.3.5.1 Increasing prevalence of cardiac disorders to boost demand for cardiovascular sensors
                                TABLE 129 MARKET FOR SENSORS, BY REGION, 2022–2029 (USD MILLION)
           7.3.6 HEART VALVES
                    7.3.6.1 Growing geriatric population to increase demand for prosthetic valves
                                TABLE 130 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
                                TABLE 131 MARKET FOR HEART VALVES, BY REGION, 2022–2029 (USD MILLION)
           7.3.7 VASCULAR GRAFTS
                    7.3.7.1 Growing number of research studies to open opportunities for growth
                                TABLE 132 MARKET FOR VASCULAR GRAFTS, BY REGION, 2022–2029 (USD MILLION)
           7.3.8 GUIDEWIRES
                    7.3.8.1 Extensive use of guidewires for guiding catheters and placing stents to boost market
                                TABLE 133 BIOMATERIALS MARKET FOR GUIDEWIRES, BY REGION, 2022–2029 (USD MILLION)
           7.3.9 OTHER CARDIOVASCULAR PRODUCTS
                    TABLE 134 MARKET FOR OTHER CARDIOVASCULAR PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
    7.4 OPHTHALMOLOGY 
          TABLE 135 MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 136 MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.4.1 CONTACT LENSES
                    7.4.1.1 High cases of refractive errors and preference for contact lenses over spectacles to drive market
                                TABLE 137 MARKET FOR CONTACT LENSES, BY REGION, 2022–2029 (USD MILLION)
           7.4.2 INTRAOCULAR LENSES
                    7.4.2.1 Increasing prevalence of cataracts to drive number of cataract surgeries performed
                                TABLE 138 MARKET FOR INTRAOCULAR LENSES, BY REGION, 2022–2029 (USD MILLION)
           7.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUE
                    7.4.3.1 Increasing funding and research activities for development of bionic eyes to drive market
                                TABLE 139 MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUE, BY REGION, 2022–2029 (USD MILLION)
           7.4.4 SYNTHETIC CORNEAS
                    7.4.4.1 Growing number of corneal blindness cases worldwide to boost demand for synthetic collagen biomaterials
                                TABLE 140 BIOMATERIALS INDUSTRY FOR SYNTHETIC CORNEAS, BY REGION, 2022–2029 (USD MILLION)
           7.4.5 OTHER OPHTHALMOLOGY PRODUCTS
                    TABLE 141 MARKET FOR OTHER OPHTHALMOLOGY PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
    7.5 DENTAL 
          TABLE 142 MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 143 MARKET FOR DENTAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.5.1 DENTAL IMPLANTS
                    7.5.1.1 Increasing awareness of dental services and improving quality of dental products to boost growth
                                TABLE 144 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN US (2016)
                                TABLE 145 MARKET FOR DENTAL IMPLANTS, BY REGION, 2022–2029 (USD MILLION)
           7.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
                    7.5.2.1 Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth
                                TABLE 146 MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2022–2029 (USD MILLION)
           7.5.3 DENTAL MEMBRANES
                    7.5.3.1 Growing use of dental membranes in oral and periodontal surgery to favor market growth
                                TABLE 147 MARKET FOR DENTAL MEMBRANES, BY REGION, 2022–2029 (USD MILLION)
           7.5.4 TISSUE REGENERATION MATERIALS
                    7.5.4.1 Increasing prevalence of periodontal disease to support growth
                                TABLE 148 BIOMATERIALS MARKET FOR TISSUE REGENERATION MATERIALS, BY REGION, 2022–2029 (USD MILLION)
    7.6 PLASTIC SURGERY 
          TABLE 149 MARKET FOR PLASTIC SURGERY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 150 MARKET FOR PLASTIC SURGERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.6.1 SOFT TISSUE FILLERS
                    7.6.1.1 Advantages such as long-lasting capacity and less allergic reactions to drive demand for soft tissue fillers
                                TABLE 151 MARKET FOR SOFT TISSUE FILLERS, BY REGION, 2022–2029 (USD MILLION)
           7.6.2 CRANIOFACIAL SURGERY PRODUCTS
                    7.6.2.1 Increasing incidence of trauma cases and head & neck cancer to increase number of craniofacial surgeries
                                TABLE 152 MARKET FOR CRANIOFACIAL SURGERY PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
           7.6.3 FACIAL WRINKLE TREATMENT DEVICES
                    7.6.3.1 Increase in demand for non-surgical treatments to drive market growth
                                TABLE 153 MARKET FOR FACIAL WRINKLE TREATMENT DEVICES, BY REGION, 2022–2029 (USD MILLION)
           7.6.4 BIOENGINEERED SKINS
                    7.6.4.1 Growing applications of bioengineered skins to boost market
                                TABLE 154 BIOMATERIALS INDUSTRY FOR BIOENGINEERED SKINS, BY REGION, 2022–2029 (USD MILLION)
           7.6.5 PERIPHERAL NERVE REPAIR DEVICES
                    7.6.5.1 Increasing incidence of trauma cases to support growth
                                TABLE 155 MARKET FOR PERIPHERAL NERVE REPAIR DEVICES, BY REGION, 2022–2029 (USD MILLION)
           7.6.6 ACELLULAR DERMAL MATRICES
                    7.6.6.1 Ability of ADMs to provide mechanical support to boost demand
                                TABLE 156 MARKET FOR ACELLULAR DERMAL MATRICES, BY REGION, 2022–2029 (USD MILLION)
    7.7 WOUND HEALING 
          TABLE 157 MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 158 MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.7.1 WOUND CLOSURE DEVICES
                    TABLE 159 MARKET FOR WOUND CLOSURE DEVICES, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 160 MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2022–2029 (USD MILLION)
                    7.7.1.1 Sutures
                               7.7.1.1.1 Ability to use sutures as advanced biologically active components to drive demand
                                              TABLE 161 MARKET FOR WOUND CLOSURE SUTURES, BY REGION, 2022–2029 (USD MILLION)
                    7.7.1.2 Staples
                               7.7.1.2.1 Ability of staples to shorten closure by 70–80% compared to sutures to drive adoption
                                              TABLE 162 BIOMATERIALS MARKET FOR WOUND CLOSURE STAPLES, BY REGION, 2022–2029 (USD MILLION)
           7.7.2 SURGICAL HEMOSTATS
                    7.7.2.1 Ability of surgical hemostats to control bleeding and reduce need for frequent blood transfusions to boost market
                                TABLE 163 MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2022–2029 (USD MILLION)
           7.7.3 INTERNAL TISSUE SEALANTS
                    7.7.3.1 Ability of internal tissue sealants to control bleeding and hemorrhages to fuel growth
                                TABLE 164 MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2022–2029 (USD MILLION)
           7.7.4 ADHESION BARRIERS
                    7.7.4.1 Ability of adhesion barriers to promote inflammatory healing process to propel growth
                                TABLE 165 MARKET FOR ADHESION BARRIERS, BY REGION, 2022–2029 (USD MILLION)
           7.7.5 HERNIA MESHES
                    7.7.5.1 Growing use of meshes in hernia repair to boost market
                                TABLE 166 MARKET FOR HERNIA MESHES, BY REGION, 2022–2029 (USD MILLION)
           7.7.6 SKIN SUBSTITUTES
                    7.7.6.1 Diverse range of combinations of skin substitutes to boost demand
                                TABLE 167 BIOMATERIALS INDUSTRY FOR SKIN SUBSTITUTES, BY REGION, 2022–2029 (USD MILLION)
    7.8 TISSUE ENGINEERING 
          TABLE 168 MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 169 MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.8.1 SCAFFOLDS
                    7.8.1.1 Rise in organ transplantation procedures to drive market
                                TABLE 170 MARKET FOR SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)
           7.8.2 NANOMATERIALS
                    7.8.2.1 Rising research on nanotechnology to drive growth
                                TABLE 171 MARKET FOR NANOMATERIALS, BY REGION, 2022–2029 (USD MILLION)
           7.8.3 INORGANIC NANOPARTICLES
                    7.8.3.1 Growing demand for nanotechnological medical products to propel market
                                TABLE 172 MARKET FOR INORGANIC NANOPARTICLES, BY REGION, 2022–2029 (USD MILLION)
    7.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 
          TABLE 173 MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
          TABLE 174 MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.9.1 SHUNTING SYSTEMS
                    7.9.1.1 Rising cases of hydrocephalus to boost market growth
                                TABLE 175 BIOMATERIALS MARKET FOR SHUNTING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
           7.9.2 CORTICAL NEURAL PROSTHETICS
                    7.9.2.1 Growing use of CNPs to treat paralyzed patients to drive growth
                                TABLE 176 MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2022–2029 (USD MILLION)
           7.9.3 HYDROGEL SCAFFOLDS
                    7.9.3.1 Increasing incidence of spinal cord surgeries to drive demand for hydrogel scaffolds
                                TABLE 177 MARKET FOR HYDROGEL SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)
           7.9.4 NEURAL STEM CELL ENCAPSULATION PRODUCTS
                    7.9.4.1 Lack of substitutes for treatment of neurotrauma to boost market growth
                                TABLE 178 MARKET FOR NEURAL STEM CELL ENCAPSULATION PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
    7.10 URINARY 
           TABLE 179 MARKET FOR URINARY APPLICATIONS, BY PRODUCT, 2022–2029 (USD MILLION)
           TABLE 180 MARKET FOR URINARY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.10.1 URINARY CATHETERS
                    7.10.1.1 Development of novel coatings for urinary catheters to boost market
                                 TABLE 181 MARKET FOR URINARY CATHETERS, BY REGION, 2022–2029 (USD MILLION)
           7.10.2 URETHRAL STENTS
                    7.10.2.1 Complications associated with urethral stents to limit market growth
                                 TABLE 182 BIOMATERIALS INDUSTRY FOR URETHRAL STENTS, BY REGION, 2022–2029 (USD MILLION)
           7.10.3 OTHER URINARY PRODUCTS
                     TABLE 183 MARKET FOR OTHER URINARY PRODUCTS, BY REGION, 2022–2029 (USD MILLION)
    7.11 OTHER APPLICATIONS 
           TABLE 184 MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           TABLE 185 MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.11.1 DRUG DELIVERY SYSTEMS
                    7.11.1.1 Dependence of drug delivery systems on biomaterials due to biocompatibility to boost growth
                                 TABLE 186 MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2022–2029 (USD MILLION)
           7.11.2 GASTROINTESTINAL
                    7.11.2.1 Wide usage of biomaterials in treatment of gastrointestinal diseases to drive market
                                 TABLE 187 MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
           7.11.3 BARIATRIC SURGERY
                    7.11.3.1 Limited number of biomaterials used for bariatric surgery to hamper growth
                                 TABLE 188 MARKET FOR BARIATRIC SURGERY, BY REGION, 2022–2029 (USD MILLION)
 
8 BIOMATERIALS MARKET, BY REGION (Page No. - 274)
    8.1 INTRODUCTION 
          TABLE 189 BIOMATERIALS INDUSTRY, BY REGION, 2022–2029 (USD MILLION)
    8.2 NORTH AMERICA 
          FIGURE 28 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
          TABLE 190 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 191 NORTH AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 192 NORTH AMERICA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 193 NORTH AMERICA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 194 NORTH AMERICA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 195 NORTH AMERICA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 196 NORTH AMERICA: BIOMATERIALS INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 197 NORTH AMERICA: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 198 NORTH AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 199 NORTH AMERICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 200 NORTH AMERICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 201 NORTH AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 202 NORTH AMERICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 203 NORTH AMERICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 204 NORTH AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 205 NORTH AMERICA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 206 NORTH AMERICA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 207 NORTH AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 208 NORTH AMERICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 209 NORTH AMERICA: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 210 NORTH AMERICA: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 211 NORTH AMERICA: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 212 NORTH AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.2.1 NORTH AMERICA: RECESSION IMPACT
           8.2.2 US
                    8.2.2.1 Rising incidence of cancer and ongoing research in developing biocompatible materials to drive market
                                TABLE 213 US: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 214 US: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 215 US: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 216 US: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 217 US: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 218 US: BIOMATERIALS INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 219 US: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 220 US: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 221 US: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 222 US: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 223 US: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 224 US: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 225 US: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 226 US: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 227 US: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 228 US: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 229 US: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 230 US: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 231 US: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 232 US: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 233 US: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 234 US: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.2.3 CANADA
                    8.2.3.1 Growing incidence of cardiovascular diseases to propel market growth
                                TABLE 235 CANADA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 236 CANADA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 237 CANADA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 238 CANADA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 239 CANADA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 240 CANADA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 241 CANADA: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 242 CANADA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 243 CANADA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 244 CANADA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 245 CANADA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 246 CANADA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 247 CANADA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 248 CANADA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 249 CANADA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 250 CANADA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 251 CANADA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 252 CANADA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 253 CANADA: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 254 CANADA: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 255 CANADA: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 256 CANADA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
    8.3 EUROPE 
          TABLE 257 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 258 EUROPE: MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 259 EUROPE: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 260 EUROPE: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 261 EUROPE: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 262 EUROPE: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 263 EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 264 EUROPE: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 265 EUROPE: BIOMATERIALS INDUSTRY FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 266 EUROPE: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 267 EUROPE: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 268 EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 269 EUROPE: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 270 EUROPE: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 271 EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 272 EUROPE: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 273 EUROPE: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 274 EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 275 EUROPE: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 276 EUROPE: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 277 EUROPE: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 278 EUROPE: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 279 EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.3.1 EUROPE: RECESSION IMPACT
           8.3.2 GERMANY
                    8.3.2.1 Rising focus on clinical research and patent approvals to aid market growth
                                TABLE 280 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 281 GERMANY: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 282 GERMANY: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 283 GERMANY: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 284 GERMANY: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 285 GERMANY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 286 GERMANY: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 287 GERMANY: BIOMATERIALS INDUSTRY FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 288 GERMANY: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 289 GERMANY: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 290 GERMANY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 291 GERMANY: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 292 GERMANY: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 293 GERMANY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 294 GERMANY: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 295 GERMANY: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 296 GERMANY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 297 GERMANY: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 298 GERMANY: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 299 GERMANY: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 300 GERMANY: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 301 GERMANY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.3.3 UK
                    8.3.3.1 Increasing availability of funds and rising number of cardiovascular procedures to support market growth
                                TABLE 302 UK: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 303 UK: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 304 UK: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 305 UK: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 306 UK: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 307 UK: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 308 UK: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 309 UK: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 310 UK: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 311 UK: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 312 UK: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 313 UK: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 314 UK: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 315 UK: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 316 UK: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 317 UK: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 318 UK: MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 319 UK: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 320 UK: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 321 UK: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 322 UK: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 323 UK: MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.3.4 FRANCE
                    8.3.4.1 Increased healthcare expenditure and structured regulatory framework to drive market
                                TABLE 324 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 325 FRANCE: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 326 FRANCE: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 327 FRANCE: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 328 FRANCE: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 329 FRANCE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 330 FRANCE: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 331 FRANCE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 332 FRANCE: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 333 FRANCE: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 334 FRANCE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 335 FRANCE: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 336 FRANCE: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 337 FRANCE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 338 FRANCE: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 339 FRANCE: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 340 FRANCE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 341 FRANCE: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 342 FRANCE: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 343 FRANCE: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 344 FRANCE: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 345 FRANCE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.3.5 ITALY
                    8.3.5.1 Rising prevalence of neurological and cardiovascular disorders to boost market growth
                                TABLE 346 ITALY: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 347 ITALY: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 348 ITALY: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 349 ITALY: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 350 ITALY: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 351 ITALY: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 352 ITALY: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 353 ITALY: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 354 ITALY: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 355 ITALY: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 356 ITALY: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 357 ITALY: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 358 ITALY: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 359 ITALY: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 360 ITALY: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 361 ITALY: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 362 ITALY: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 363 ITALY: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 364 ITALY: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 365 ITALY: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 366 ITALY: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 367 ITALY: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.3.6 SPAIN
                    8.3.6.1 Increased focus on research for biomaterial development to propel market growth
                                TABLE 368 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 369 SPAIN: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 370 SPAIN: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 371 SPAIN: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 372 SPAIN: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 373 SPAIN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 374 SPAIN: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 375 SPAIN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 376 SPAIN: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 377 SPAIN: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 378 SPAIN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 379 SPAIN: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 380 SPAIN: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 381 SPAIN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 382 SPAIN: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 383 SPAIN: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 384 SPAIN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 385 SPAIN: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 386 SPAIN: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 387 SPAIN: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 388 SPAIN: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 389 SPAIN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.3.7 REST OF EUROPE
                    TABLE 390 REST OF EUROPE: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 391 REST OF EUROPE: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 392 REST OF EUROPE: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 393 REST OF EUROPE: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 394 REST OF EUROPE: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 395 REST OF EUROPE: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 396 REST OF EUROPE: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 397 REST OF EUROPE: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 398 REST OF EUROPE: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 399 REST OF EUROPE: SPINE SURGERY APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 400 REST OF EUROPE: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 401 REST OF EUROPE: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 402 REST OF EUROPE: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 403 REST OF EUROPE: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 404 REST OF EUROPE: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 405 REST OF EUROPE: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 406 REST OF EUROPE: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 407 REST OF EUROPE: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 408 REST OF EUROPE: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 409 REST OF EUROPE: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 410 REST OF EUROPE: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 411 REST OF EUROPE: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
    8.4 ASIA PACIFIC 
          FIGURE 29 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
          TABLE 412 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 413 ASIA PACIFIC: MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 414 ASIA PACIFIC: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 415 ASIA PACIFIC: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 416 ASIA PACIFIC: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 417 ASIA PACIFIC: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 418 ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 419 ASIA PACIFIC: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 420 ASIA PACIFIC: BIOMATERIALS INDUSTRY FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 421 ASIA PACIFIC: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 422 ASIA PACIFIC: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 423 ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 424 ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 425 ASIA PACIFIC: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 426 ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 427 ASIA PACIFIC: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 428 ASIA PACIFIC: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 429 ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 430 ASIA PACIFIC: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 431 ASIA PACIFIC: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 432 ASIA PACIFIC: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 433 ASIA PACIFIC: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 434 ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.4.1 ASIA PACIFIC: RECESSION IMPACT
           8.4.2 CHINA
                    8.4.2.1 Lucrative medical devices industry and large geriatric population to drive market
                                TABLE 435 CHINA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 436 CHINA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 437 CHINA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 438 CHINA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 439 CHINA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 440 CHINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 441 CHINA: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 442 CHINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 443 CHINA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 444 CHINA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 445 CHINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 446 CHINA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 447 CHINA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 448 CHINA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 449 CHINA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 450 CHINA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 451 CHINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 452 CHINA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 453 CHINA: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 454 CHINA: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 455 CHINA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 456 CHINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.4.3 JAPAN
                    8.4.3.1 Growing medical devices industry and rising aging population to support market growth
                                TABLE 457 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 458 JAPAN: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 459 JAPAN: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 460 JAPAN: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 461 JAPAN: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 462 JAPAN: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 463 JAPAN: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 464 JAPAN: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 465 JAPAN: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 466 JAPAN: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 467 JAPAN: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 468 JAPAN: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 469 JAPAN: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 470 JAPAN: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 471 JAPAN: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 472 JAPAN: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 473 JAPAN: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 474 JAPAN: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 475 JAPAN: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 476 JAPAN: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 477 JAPAN: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 478 JAPAN: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.4.4 INDIA
                    8.4.4.1 Large population base and growing focus on medical tourism to aid market growth
                                TABLE 479 INDIA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 480 INDIA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 481 INDIA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 482 INDIA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 483 INDIA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 484 INDIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 485 INDIA: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 486 INDIA: BIOMATERIALS INDUSTRY FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 487 INDIA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 488 INDIA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 489 INDIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 490 INDIA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 491 INDIA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 492 INDIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 493 INDIA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 494 INDIA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 495 INDIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 496 INDIA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 497 INDIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 498 INDIA: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 499 INDIA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 500 INDIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.4.5 SOUTH KOREA
                    8.4.5.1 High demand for healthcare services and treatments to support market growth
                                TABLE 501 SOUTH KOREA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 502 SOUTH KOREA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 503 SOUTH KOREA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 504 SOUTH KOREA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 505 SOUTH KOREA: FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 506 SOUTH KOREA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 507 SOUTH KOREA: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 508 SOUTH KOREA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 509 SOUTH KOREA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 510 SOUTH KOREA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 511 SOUTH KOREA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 512 SOUTH KOREA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 513 SOUTH KOREA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 514 SOUTH KOREA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 515 SOUTH KOREA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 516 SOUTH KOREA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 517 SOUTH KOREA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 518 SOUTH KOREA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 519 SOUTH KOREA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 520 SOUTH KOREA: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 521 SOUTH KOREA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 522 SOUTH KOREA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.4.6 AUSTRALIA
                    8.4.6.1 Increasing incidence of sports injuries and growing government investment in research to aid market growth
                                TABLE 523 AUSTRALIA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 524 AUSTRALIA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 525 AUSTRALIA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 526 AUSTRALIA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 527 AUSTRALIA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 528 AUSTRALIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 529 AUSTRALIA: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 530 AUSTRALIA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 531 AUSTRALIA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 532 AUSTRALIA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 533 AUSTRALIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 534 AUSTRALIA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 535 AUSTRALIA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 536 AUSTRALIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 537 AUSTRALIA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 538 AUSTRALIA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 539 AUSTRALIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 540 AUSTRALIA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 541 AUSTRALIA: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 542 AUSTRALIA: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 543 AUSTRALIA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 544 AUSTRALIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.4.7 REST OF ASIA PACIFIC
                    TABLE 545 REST OF ASIA PACIFIC: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 546 REST OF ASIA PACIFIC: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 547 REST OF ASIA PACIFIC: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 548 REST OF ASIA PACIFIC: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 549 REST OF ASIA PACIFIC: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 550 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 551 REST OF ASIA PACIFIC: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 552 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 553 REST OF ASIA PACIFIC: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 554 REST OF ASIA PACIFIC: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 555 REST OF ASIA PACIFIC: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 556 REST OF ASIA PACIFIC: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 557 REST OF ASIA PACIFIC: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 558 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 559 REST OF ASIA PACIFIC: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 560 REST OF ASIA PACIFIC: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 561 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 562 REST OF ASIA PACIFIC: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 563 REST OF ASIA PACIFIC: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 564 REST OF ASIA PACIFIC: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 565 REST OF ASIA PACIFIC: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 566 REST OF ASIA PACIFIC: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
    8.5 LATIN AMERICA 
          TABLE 567 LATIN AMERICA: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 568 LATIN AMERICA: MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 569 LATIN AMERICA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 570 LATIN AMERICA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 571 LATIN AMERICA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 572 LATIN AMERICA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 573 LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 574 LATIN AMERICA: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 575 LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 576 LATIN AMERICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 577 LATIN AMERICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 578 LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 579 LATIN AMERICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 580 LATIN AMERICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 581 LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 582 LATIN AMERICA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 583 LATIN AMERICA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 584 LATIN AMERICA: MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 585 LATIN AMERICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 586 LATIN AMERICA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 587 LATIN AMERICA: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 588 LATIN AMERICA: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 589 LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.5.1 LATIN AMERICA: RECESSION IMPACT
           8.5.2 BRAZIL
                    8.5.2.1 Gradual increase in pharmaceutical R&D to support market growth
                                TABLE 590 BRAZIL: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 591 BRAZIL: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 592 BRAZIL: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 593 BRAZIL: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 594 BRAZIL: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 595 BRAZIL: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 596 BRAZIL: BIOMATERIALS INDUSTRY FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 597 BRAZIL: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 598 BRAZIL: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 599 BRAZIL: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 600 BRAZIL: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 601 BRAZIL: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 602 BRAZIL: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 603 BRAZIL: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 604 BRAZIL: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 605 BRAZIL: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 606 BRAZIL: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 607 BRAZIL: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 608 BRAZIL: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 609 BRAZIL: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 610 BRAZIL: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 611 BRAZIL: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.5.3 MEXICO
                    8.5.3.1 Increasing incidence of diabetes and growing geriatric population to aid market growth
                                TABLE 612 MEXICO: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 613 MEXICO: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 614 MEXICO: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 615 MEXICO: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 616 MEXICO: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 617 MEXICO: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 618 MEXICO: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 619 MEXICO: BIOMATERIALS INDUSTRY FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 620 MEXICO: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 621 MEXICO: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 622 MEXICO: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 623 MEXICO: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 624 MEXICO: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 625 MEXICO: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 626 MEXICO: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 627 MEXICO: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 628 MEXICO: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 629 MEXICO: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 630 MEXICO: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 631 MEXICO: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 632 MEXICO: MARKET FOR URINARY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 633 MEXICO: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.5.4 ARGENTINA
                    8.5.4.1 Increased incidence of cardiovascular diseases to aid market growth
                                TABLE 634 ARGENTINA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 635 ARGENTINA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 636 ARGENTINA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 637 ARGENTINA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 638 ARGENTINA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 639 ARGENTINA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 640 ARGENTINA: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 641 ARGENTINA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 642 ARGENTINA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 643 ARGENTINA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 644 ARGENTINA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 645 ARGENTINA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 646 ARGENTINA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 647 ARGENTINA: MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 648 ARGENTINA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 649 ARGENTINA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 650 ARGENTINA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 651 ARGENTINA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 652 ARGENTINA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 653 ARGENTINA: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 654 ARGENTINA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 655 ARGENTINA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.5.5 REST OF LATIN AMERICA
                    TABLE 656 REST OF LATIN AMERICA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 657 REST OF LATIN AMERICA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 658 REST OF LATIN AMERICA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 659 REST OF LATIN AMERICA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 660 REST OF LATIN AMERICA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 661 REST OF LATIN AMERICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 662 REST OF LATIN AMERICA: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 663 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 664 REST OF LATIN AMERICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 665 REST OF LATIN AMERICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 666 REST OF LATIN AMERICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 667 REST OF LATIN AMERICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 668 REST OF LATIN AMERICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 669 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 670 REST OF LATIN AMERICA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 671 REST OF LATIN AMERICA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 672 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 673 REST OF LATIN AMERICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 674 REST OF LATIN AMERICA: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 675 REST OF LATIN AMERICA: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 676 REST OF LATIN AMERICA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 677 REST OF LATIN AMERICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
    8.6 MIDDLE EAST 
          TABLE 678 MIDDLE EAST: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
          TABLE 679 MIDDLE EAST: MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 680 MIDDLE EAST: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 681 MIDDLE EAST: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 682 MIDDLE EAST: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 683 MIDDLE EAST: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 684 MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
          TABLE 685 MIDDLE EAST: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 686 MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 687 MIDDLE EAST: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 688 MIDDLE EAST: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 689 MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 690 MIDDLE EAST: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 691 MIDDLE EAST: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 692 MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 693 MIDDLE EAST: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 694 MIDDLE EAST: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 695 MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 696 MIDDLE EAST: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 697 MIDDLE EAST: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 698 MIDDLE EAST: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 699 MIDDLE EAST: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
          TABLE 700 MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.6.1 MIDDLE EAST: RECESSION IMPACT
           8.6.2 GCC COUNTRIES
                    TABLE 701 GCC COUNTRIES: BIOMATERIALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
                    TABLE 702 GCC COUNTRIES: MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 703 GCC COUNTRIES: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 704 GCC COUNTRIES: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 705 GCC COUNTRIES: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 706 GCC COUNTRIES: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 707 GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 708 GCC COUNTRIES: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 709 GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 710 GCC COUNTRIES: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 711 GCC COUNTRIES: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 712 GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 713 GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 714 GCC COUNTRIES: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 715 GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 716 GCC COUNTRIES: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 717 GCC COUNTRIES: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 718 GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 719 GCC COUNTRIES: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 720 GCC COUNTRIES: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 721 GCC COUNTRIES: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 722 GCC COUNTRIES: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 723 GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    8.6.2.1 Saudi Arabia
                               8.6.2.1.1 Increasing prevalence of cardiovascular diseases to drive market
                                              TABLE 724 SAUDI ARABIA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 725 SAUDI ARABIA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 726 SAUDI ARABIA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 727 SAUDI ARABIA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 728 SAUDI ARABIA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 729 SAUDI ARABIA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                              TABLE 730 SAUDI ARABIA: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 731 SAUDI ARABIA: MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 732 SAUDI ARABIA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 733 SAUDI ARABIA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 734 SAUDI ARABIA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 735 SAUDI ARABIA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 736 SAUDI ARABIA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 737 SAUDI ARABIA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 738 SAUDI ARABIA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 739 SAUDI ARABIA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 740 SAUDI ARABIA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 741 SAUDI ARABIA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 742 SAUDI ARABIA: BIOMATERIALS MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 743 SAUDI ARABIA: MARKET FOR NEUROLOGICAL/ CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 744 SAUDI ARABIA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 745 SAUDI ARABIA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    8.6.2.2 United Arab Emirates
                               8.6.2.2.1 Growing interest in plastic surgeries and rising number of occupational injuries to drive market
                                              TABLE 746 UNITED ARAB EMIRATES: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 747 UNITED ARAB EMIRATES: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 748 UNITED ARAB EMIRATES: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 749 UNITED ARAB EMIRATES: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 750 UNITED ARAB EMIRATES: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 751 UNITED ARAB EMIRATES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                              TABLE 752 UNITED ARAB EMIRATES: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 753 UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 754 UNITED ARAB EMIRATES: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 755 UNITED ARAB EMIRATES: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 756 UNITED ARAB EMIRATES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 757 UNITED ARAB EMIRATES: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 758 UNITED ARAB EMIRATES: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 759 UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 760 UNITED ARAB EMIRATES: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 761 UNITED ARAB EMIRATES: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 762 UNITED ARAB EMIRATES: MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 763 UNITED ARAB EMIRATES: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 764 UNITED ARAB EMIRATES: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 765 UNITED ARAB EMIRATES: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 766 UNITED ARAB EMIRATES: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                              TABLE 767 UNITED ARAB EMIRATES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    8.6.2.3 Rest of GCC countries
                                TABLE 768 REST OF GCC COUNTRIES: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 769 REST OF GCC COUNTRIES: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 770 REST OF GCC COUNTRIES: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 771 REST OF GCC COUNTRIES: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 772 REST OF GCC COUNTRIES: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 773 REST OF GCC COUNTRIES: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                                TABLE 774 REST OF GCC COUNTRIES: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 775 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 776 REST OF GCC COUNTRIES: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 777 REST OF GCC COUNTRIES: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 778 REST OF GCC COUNTRIES: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 779 REST OF GCC COUNTRIES: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 780 REST OF GCC COUNTRIES: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 781 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 782 REST OF GCC COUNTRIES: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 783 REST OF GCC COUNTRIES: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 784 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 785 REST OF GCC COUNTRIES: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 786 REST OF GCC COUNTRIES: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 787 REST OF GCC COUNTRIES: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 788 REST OF GCC COUNTRIES: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                                TABLE 789 REST OF GCC COUNTRIES: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.6.3 REST OF MIDDLE EAST
                    TABLE 790 REST OF MIDDLE EAST: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 791 REST OF MIDDLE EAST: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 792 REST OF MIDDLE EAST: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 793 REST OF MIDDLE EAST: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 794 REST OF MIDDLE EAST: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 795 REST OF MIDDLE EAST: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 796 REST OF MIDDLE EAST: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 797 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 798 REST OF MIDDLE EAST: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 799 REST OF MIDDLE EAST: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 800 REST OF MIDDLE EAST: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 801 REST OF MIDDLE EAST: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 802 REST OF MIDDLE EAST: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 803 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 804 REST OF MIDDLE EAST: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 805 REST OF MIDDLE EAST: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 806 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 807 REST OF MIDDLE EAST: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 808 REST OF MIDDLE EAST: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 809 REST OF MIDDLE EAST: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 810 REST OF MIDDLE EAST: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 811 REST OF MIDDLE EAST: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
    8.7 AFRICA 
           8.7.1 INCREASING FOCUS ON HEALTHCARE AND RISING NUMBER OF COLLABORATIONS TO SUPPORT MARKET GROWTH
                    TABLE 812 AFRICA: BIOMATERIALS MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 813 AFRICA: MARKET FOR METALLIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 814 AFRICA: MARKET FOR CERAMIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 815 AFRICA: MARKET FOR POLYMERIC BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 816 AFRICA: MARKET FOR NATURAL BIOMATERIALS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 817 AFRICA: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
                    TABLE 818 AFRICA: MARKET FOR CARDIOVASCULAR APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 819 AFRICA: BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 820 AFRICA: JOINT REPLACEMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 821 AFRICA: SPINE SURGERIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 822 AFRICA: MOTION PRESERVATION & DYNAMIC STABILIZATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 823 AFRICA: BIORESORBABLE TISSUE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 824 AFRICA: FRACTURE FIXATION MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 825 AFRICA: BIOMATERIALS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 826 AFRICA: MARKET FOR DENTAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 827 AFRICA: MARKET FOR PLASTIC SURGERY APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 828 AFRICA: BIOMATERIALS MARKET FOR WOUND HEALING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 829 AFRICA: WOUND CLOSURE DEVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 830 AFRICA: MARKET FOR TISSUE ENGINEERING APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 831 AFRICA: MARKET FOR NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 832 AFRICA: MARKET FOR URINARY APPLICATIONS APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
                    TABLE 833 AFRICA: BIOMATERIALS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
           8.7.2 AFRICA: RECESSION IMPACT
 
9 COMPETITIVE LANDSCAPE (Page No. - 594)
    9.1 INTRODUCTION 
    9.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
          FIGURE 30 BIOMATERIALS MARKET: STRATEGIES ADOPTED
    9.3 REVENUE SHARE ANALYSIS 
          FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS (2020–2023)
    9.4 MARKET SHARE ANALYSIS 
          FIGURE 32 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
          TABLE 834 BIOMATERIALS MARKET: DEGREE OF COMPETITION
    9.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 
           9.5.1 STARS
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
                    FIGURE 33 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
           9.5.5 COMPANY FOOTPRINT
                    FIGURE 34 BIOMATERIALS MARKET: COMPANY FOOTPRINT
                    TABLE 835 BIOMATERIALS MARKET: TYPE FOOTPRINT
                    TABLE 836 BIOMATERIALS MARKET: REGIONAL FOOTPRINT
    9.6 COMPANY EVALUATION MATRIX: START-UPS/SMES 
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 RESPONSIVE COMPANIES
           9.6.3 DYNAMIC COMPANIES
           9.6.4 STARTING BLOCKS
                    FIGURE 35 BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
           9.6.5 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
                    TABLE 837 BIOMATERIALS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
                    TABLE 838 BIOMATERIALS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
    9.7 VALUATION AND FINANCIAL METRICS OF BIOMATERIALS VENDORS 
          FIGURE 36 EV/EBITDA OF KEY VENDORS
          FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
    9.8 BRAND/PRODUCT COMPARATIVE ANALYSIS 
          FIGURE 38 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL
           9.8.1 BASF SE
           9.8.2 COVESTRO AG
           9.8.3 CELANESE CORPORATION
           9.8.4 CARPENTER TECHNOLOGY CORPORATION
           9.8.5 EVONIK INDUSTRIES AG
           9.8.6 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY METALLIC BIOMATERIAL
                    FIGURE 39 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY METALLIC BIOMATERIAL
           9.8.7 CARPENTER TECHNOLOGY CORPORATION
           9.8.8 SOLESIS
           9.8.9 AMETEK, INC.
    9.9 COMPETITIVE SCENARIO 
           9.9.1 PRODUCT LAUNCHES
                    TABLE 839 BIOMATERIALS MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2024
           9.9.2 DEALS
                    TABLE 840 BIOMATERIALS MARKET: DEALS, JANUARY 2021–JANUARY 2024
           9.9.3 EXPANSIONS
                    TABLE 841 BIOMATERIALS MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2024
           9.9.4 OTHER DEVELOPMENTS
                    TABLE 842 BIOMATERIALS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2024
 
10 COMPANY PROFILES (Page No. - 617)
     10.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             10.1.1 BASF SE
                        TABLE 843 BASF SE: COMPANY OVERVIEW
                        FIGURE 40 BASF SE: COMPANY SNAPSHOT (2022)
                        TABLE 844 BASF SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 845 BASF SE: PRODUCT LAUNCHES
                        TABLE 846 BASF SE: DEALS
                        TABLE 847 BASF SE: OTHER DEVELOPMENTS
             10.1.2 COVESTRO AG
                        TABLE 848 COVESTRO AG: COMPANY OVERVIEW
                        FIGURE 41 COVESTRO AG: COMPANY SNAPSHOT (2022)
                        TABLE 849 COVESTRO AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 850 COVESTRO AG: PRODUCT LAUNCHES
                        TABLE 851 COVESTRO AG: DEALS
                        TABLE 852 COVESTRO AG: OTHER DEVELOPMENTS
             10.1.3 CELANESE CORPORATION
                        TABLE 853 CELANESE CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 CELANESE CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 854 CELANESE CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 855 CELANESE CORPORATION: DEALS
                        TABLE 856 CELANESE CORPORATION: EXPANSIONS
                        TABLE 857 CELANESE CORPORATION: OTHER DEVELOPMENTS
             10.1.4 CARPENTER TECHNOLOGY CORPORATION
                        TABLE 858 CARPENTER TECHNOLOGY CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 859 CARPENTER TECHNOLOGY CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             10.1.5 EVONIK INDUSTRIES AG
                        TABLE 860 EVONIK INDUSTRIES AG: COMPANY OVERVIEW
                        FIGURE 44 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2022)
                        TABLE 861 EVONIK INDUSTRIES AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 862 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES
                        TABLE 863 EVONIK INDUSTRIES AG: DEALS
             10.1.6 DSM
                        TABLE 864 DSM: COMPANY OVERVIEW
                        FIGURE 45 DSM: COMPANY SNAPSHOT (2022)
                        TABLE 865 DSM: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 866 DSM: DEALS
                        TABLE 867 DSM: OTHER DEVELOPMENTS
             10.1.7 CORBION NV
                        TABLE 868 CORBION NV: COMPANY OVERVIEW
                        FIGURE 46 CORBION NV: COMPANY SNAPSHOT (2022)
                        TABLE 869 CORBION NV: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 870 CORBION NV: DEALS
                        TABLE 871 CORBION NV: EXPANSIONS
             10.1.8 VICTREX PLC
                        TABLE 872 VICTREX PLC: COMPANY OVERVIEW
                        FIGURE 47 VICTREX PLC: COMPANY SNAPSHOT (2022)
                        TABLE 873 VICTREX PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 874 VICTREX PLC: PRODUCT LAUNCHES
                        TABLE 875 VICTREX PLC: DEALS
                        TABLE 876 VICTREX PLC: EXPANSIONS
             10.1.9 CERAMTEC GMBH
                        TABLE 877 CERAMTEC GMBH: COMPANY OVERVIEW
                        FIGURE 48 CERAMTEC GMBH: COMPANY SNAPSHOT (2021)
                        TABLE 878 CERAMTEC GMBH: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             10.1.10 MITSUBISHI CHEMICAL CORPORATION
                        TABLE 879 MITSUBISHI CHEMICAL CORPORATION: COMPANY OVERVIEW
                        FIGURE 49 MITSUBISHI CHEMICAL CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 880 MITSUBISHI CHEMICAL CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             10.1.11 COORSTEK INC.
                        TABLE 881 COORSTEK INC.: COMPANY OVERVIEW
                        TABLE 882 COORSTEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 883 COORSTEK INC.: EXPANSIONS
             10.1.12 BERKELEY ADVANCED BIOMATERIALS
                        TABLE 884 BERKELEY ADVANCED BIOMATERIALS: COMPANY OVERVIEW
                        TABLE 885 BERKELEY ADVANCED BIOMATERIALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
             10.1.13 CAM BIOCERAMICS B.V.
                        TABLE 886 CAM BIOCERAMICS B.V.: COMPANY OVERVIEW
                        TABLE 887 CAM BIOCERAMICS B.V.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 888 CAM BIOCERAMICS B.V.: DEALS
             10.1.14 ZEUS COMPANY INC.
                        TABLE 889 ZEUS COMPANY INC.: COMPANY OVERVIEW
                        TABLE 890 ZEUS COMPANY INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 891 ZEUS COMPANY INC.: PRODUCT LAUNCHES
                        TABLE 892 ZEUS COMPANY INC.: DEALS
                        TABLE 893 ZEUS COMPANY INC.: EXPANSIONS
             10.1.15 AMETEK INC.
                        TABLE 894 AMETEK.INC.: COMPANY OVERVIEW
                        FIGURE 50 AMETEK.INC.: COMPANY SNAPSHOT (2022)
                        TABLE 895 AMETEK INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
                        TABLE 896 AMETEK INC.: DEALS
                        TABLE 897 AMETEK.INC.: EXPANSIONS
             10.1.16 GELITA AG
                        TABLE 898 GELITA AG: COMPANY OVERVIEW
                        TABLE 899 GELITA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
     10.2 OTHER PLAYERS 
             10.2.1 COLLAGEN SOLUTIONS (US) LLC)
                        TABLE 900 COLLAGEN SOLUTIONS (US) LLC: BUSINESS OVERVIEW
             10.2.2 BIOCOMPOSITES
                        TABLE 901 BIOCOMPOSITES: COMPANY OVERVIEW
             10.2.3 NOBLE BIOMATERIALS, INC.
                        TABLE 902 NOBLE BIOMATERIALS, INC.: COMPANY OVERVIEW
             10.2.4 REGENITY
                        TABLE 903 REGENITY: COMPANY OVERVIEW
             10.2.5 KURARAY CO., LTD.
                        TABLE 904 KURARAY CO., LTD.: COMPANY OVERVIEW
             10.2.6 SOLESIS
                        TABLE 905 SOLESIS: COMPANY OVERVIEW
             10.2.7 INSTITUT STRAUMANN AG
                        TABLE 906 INSTITUT STRAUMANN AG: COMPANY OVERVIEW
             10.2.8 FOSTER CORPORATION
                        TABLE 907 FOSTER CORPORATION: COMPANY OVERVIEW
             10.2.9 CDI PRODUCTS
                        TABLE 908 CDI PRODUCTS: COMPANY OVERVIEW
 
11 APPENDIX (Page No. - 689)
     11.1 DISCUSSION GUIDE 
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     11.3 CUSTOMIZATION OPTIONS 
     11.4 RELATED REPORTS 
     11.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the biomaterials market. The secondary sources used for this study include the Journal of Biomedical Nanotechnology, Journal of Materials Science, Materials Science and Engineering, Journal of Biomedical Materials Research, Biomedical Engineering Society (BMES), Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, global product revenues, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data was collected and analyzed to arrive at the overall size of the global biomaterials market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Biomaterials  Market Size, and Share

Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The global size of the biomaterials market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The major players in the industry and market have been identified through extensive primary and secondary research.
  • The product and company revenues generated from the biomaterials business of players operating in the market have been determined through secondary research and primary analysis.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Market Size Estimation Methodology-Bottom-up approach

Biomaterials  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach-

Biomaterials  Market Size, and Share

Data Triangulation

After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Biomaterials refer to substances that have been engineered to interact with biological systems for medical purposes. These materials are designed to be compatible with living tissues and can be used in various medical applications, such as implants, prosthetics, drug delivery systems, and tissue engineering. The primary goal of biomaterials is to enhance or replace the function of a body part, promote healing, and improve overall health. These materials are selected and engineered based on their biocompatibility, mechanical properties, and ability to integrate seamlessly with the biological environment. Biomaterials play a crucial role in advancing medical technologies and improving patient outcomes.

Key Stakeholders

  • Biomaterial product manufacturing companies
  • Healthcare service providers (including hospitals & specialty clinics)
  • National and regional research boards and organizations
  • Research & development companies
  • Clinical research organizations (CROs)
  • Healthcare technology companies
  • Biotechnology companies
  • Research laboratories & academic institutes
  • Market research & consulting firms
  • Regulatory bodies

The main objectives of this study are as follows:

  • To define, describe, and forecast the biomaterials market by type, application, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall biomaterials market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East {GCC [Saudi Arabia (KSA), United Arab Emirates (UAE), and the Rest of GCC] and the Rest of Middle East}, and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.
  • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report with additional efforts:

Product-Level Information

Country-wise Information:

  • Analysis for additional countries (up to five)

Company Information:

  • Detailed analysis and profiling of additional key market players across the globe
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
BT 1556
Published ON
Mar, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback